These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 19846929

  • 1. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
    Evans S, Dizeyi N, Abrahamsson PA, Persson J.
    Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929
    [Abstract] [Full Text] [Related]

  • 2. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
    Yazici S, Kim SJ, Busby JE, He J, Thaker P, Yokoi K, Fan D, Fidler IJ.
    Prostate; 2005 Nov 01; 65(3):203-15. PubMed ID: 15948138
    [Abstract] [Full Text] [Related]

  • 3. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry.
    Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.
    In Vivo; 2005 Nov 01; 19(1):179-83. PubMed ID: 15796171
    [Abstract] [Full Text] [Related]

  • 4. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.
    Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R.
    Anticancer Res; 2005 Mar 15; 25(1A):139-47. PubMed ID: 15816531
    [Abstract] [Full Text] [Related]

  • 6. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.
    Smith PC, Keller ET.
    Prostate; 2001 Jun 15; 48(1):47-53. PubMed ID: 11391686
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E, Schally AV, Buchholz S, Rick FG, Halmos G, Mile M, Groot K, Hohla F, Zarandi M, Varga JL.
    Prostate; 2008 Dec 01; 68(16):1763-72. PubMed ID: 18729085
    [Abstract] [Full Text] [Related]

  • 8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
    Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, Díaz-Laviada I.
    Apoptosis; 2006 Jan 01; 11(1):89-99. PubMed ID: 16374544
    [Abstract] [Full Text] [Related]

  • 10. A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
    Weng JR, Tsai CH, Kulp SK, Wang D, Lin CH, Yang HC, Ma Y, Sargeant A, Chiu CF, Tsai MH, Chen CS.
    Cancer Res; 2007 Aug 15; 67(16):7815-24. PubMed ID: 17699787
    [Abstract] [Full Text] [Related]

  • 11. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [Abstract] [Full Text] [Related]

  • 12. [Grape seed extract inhibits the growth of prostate cancer PC-3 cells].
    Huang TT, Shang XJ, Yao GH, Ge JP, Teng WH, Sun Y, Huang YF.
    Zhonghua Nan Ke Xue; 2008 Apr 01; 14(4):331-3. PubMed ID: 18481426
    [Abstract] [Full Text] [Related]

  • 13. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
    El Hilali N, Rubio N, Blanco J.
    Clin Cancer Res; 2005 Feb 01; 11(3):1253-8. PubMed ID: 15709196
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of herbal supplements in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS, Figg WD.
    Anticancer Res; 2003 Feb 01; 23(5A):3585-90. PubMed ID: 14666653
    [Abstract] [Full Text] [Related]

  • 15. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
    Jiang J, Loganathan J, Eliaz I, Terry C, Sandusky GE, Sliva D.
    Int J Oncol; 2012 May 01; 40(5):1339-44. PubMed ID: 22293856
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.
    Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5480-7. PubMed ID: 17875778
    [Abstract] [Full Text] [Related]

  • 17. Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer.
    Ranga RS, Girija R, Nur-e-Alam M, Sathishkumar S, Akbarsha MA, Thirugnanam S, Rohr J, Ahmed MM, Chendil D.
    Cancer Chemother Pharmacol; 2004 Jul 15; 54(1):7-15. PubMed ID: 15042313
    [Abstract] [Full Text] [Related]

  • 18. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
    Roomi MW, Roomi NW, Kalinovsky T, Rath M, Niedzwiecki A.
    Integr Cancer Ther; 2009 Jun 15; 8(2):168-76. PubMed ID: 19679626
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR.
    Clin Cancer Res; 2003 Jul 15; 9(7):2510-9. PubMed ID: 12855625
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2284-9. PubMed ID: 19080333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.